Alpha 2.0
Login Register
» Authors » Marta Popeda

Marta Popeda

Explore the profile of Marta Popeda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 247
Followers 0
Related Specialties
Oncology
Biochemistry
Cell Biology
Top 10 Co-Authors
Michal Bienkowski
Anna J Zaczek
Rafal Peksa
Wojciech Biernat
Natalia Bednarz-Knoll
Michal Kunc
Jolanta Szade
Magdalena Niemira
Ewelina Stoczynska-Fidelus
Aleksandra Markiewicz
Published In
Cancers (Basel)
Sci Rep
Diagnostics (Basel)
Cell Mol Biol Lett
J Neurosurg
Affiliations
Soon will be listed here.
Recent Articles
1.
Improved accuracy of delayed cerebral ischemia diagnosis with plasma nitric oxide synthase 3, nicotinamide adenine dinucleotide phosphate, and 8-iso-prostaglandin F2α
Wisniewski K, Zaczkowski K, Popeda M, Urbanowicz K, Szmyd B, Price B, et al.
J Neurosurg . 2025 Jan; 1-12. PMID: 39854699
Objective: The pathophysiology of delayed cerebral ischemia (DCI) is not fully elucidated. The lack of accurate diagnostic tools increases the probability of delayed diagnosis and timely treatment. The authors assessed...
2.
Complete blood counts as potential risk factors of early dissemination to liver and lungs in resected colorectal cancer: a retrospective cohort study
Popeda M, Zok J, Tomasik B, Duchnowska R, Bienkowski M
Int J Colorectal Dis . 2025 Jan; 40(1):21. PMID: 39836241
Purpose: Liver and lung metastases demonstrate distinct biological, particularly immunological, characteristics. We investigated whether preoperative complete blood count (CBC) parameters, which may reflect the immune system condition, predict early dissemination...
3.
P-selectin glycoprotein ligand-1 is diversely expressed in the primary tumour and venous thrombus of clear cell renal cancer and correlates with poor overall survival
Peksa R, Sharma S, Kunc M, Popeda M, Qu L, Frankiewicz M, et al.
Contemp Oncol (Pozn) . 2024 Nov; 28(3):253-259. PMID: 39512528
Introduction: In clear cell renal cell carcinoma (ccRCC), intravascular extension often results in neoplastic thrombus formation, impacting patient outcomes. Material And Methods: We assessed P-selectin glycoprotein ligand-1 (PSGL-1) expression in...
4.
Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden
Serafin P, Popeda M, Bulak K, Zwara A, Galikowska-Bogut B, Przychodzka A, et al.
Mol Metab . 2024 Sep; 89:102035. PMID: 39304062
Objective: CD73 (ecto-5'-nucleotidase, NT5E), a cell-surface enzyme converting 5'-AMP to adenosine, is crucial for cancer progression. However, its role in the tumorigenesis process remains mostly obscure. We aimed to demonstrate...
5.
Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment
Popeda M, Kowalski K, Wenta T, Beznoussenko G, Rychlowski M, Mironov A, et al.
Exp Mol Med . 2024 Sep; 56(9):2016-2032. PMID: 39218980
Micronuclei (MN) can form through many mechanisms, including the breakage of aberrant cytokinetic chromatin bridges. The frequent observation of MN in tumors suggests that they might not merely be passive...
6.
High tumour-infiltrating lymphocytes correlate with distinct gene expression profile and favourable survival in single hormone receptor-positive breast cancer
Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M, et al.
Contemp Oncol (Pozn) . 2024 May; 28(1):75-83. PMID: 38800535
Introduction: This study aimed to evaluate the impact of tumour-infiltrating lymphocytes (TILs) on the expression of immune-related genes and prognosis in single hormone receptor-positive breast cancer. Material and methods: Tumour-infiltrating...
7.
Evaluation of CSF 8-iso-prostaglandin F2α and erythrocyte anisocytosis as prognostic biomarkers for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Wisniewski K, Zaczkowski K, Szmyd B, Popeda M, Bienkowski M, Posmyk B, et al.
Sci Rep . 2024 May; 14(1):11302. PMID: 38760404
Delayed cerebral ischemia (DCI) is a serious, life-threatening, complication affecting patients who have survived the initial bleeding from a ruptured intracranial aneurysm. Due to the challenging diagnosis, potential DCI prognostic...
8.
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs
Gorska-Arcisz M, Popeda M, Braun M, Piasecka D, Nowak J, Kitowska K, et al.
Cell Mol Biol Lett . 2024 May; 29(1):71. PMID: 38745155
Background: Genetic abnormalities in the FGFR signalling occur in 40% of breast cancer (BCa) patients resistant to anti-ER therapy, which emphasizes the potential of FGFR-targeting strategies. Recent findings indicate that...
9.
Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
Cichowska-Cwalinska N, Bienkowski M, Popeda M, Drozka M, Rutkowski J, Jassem J, et al.
Front Oncol . 2023 Oct; 13:1234953. PMID: 37886164
Aim: We hypothesized that markers of inflammation correlate with response to radiotherapy in patients with non-metastatic laryngeal cancer (LC). Our aim was to assess peripheral and local markers of inflammation...
10.
FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation
Mieczkowski K, Popeda M, Lesniak D, Sadej R, Kitowska K
J Mammary Gland Biol Neoplasia . 2023 May; 28(1):9. PMID: 37191822
The role of fibroblast growth factor receptor 2 (FGFR2), an important mediator of stromal paracrine and autocrine signals, in mammary gland morphogenesis and breast cancer has been extensively studied over...